BACTI_B: Infection prevention technology and strong financial growth underpin ambitious 2030 targets

About this update from Bactiguard Holding Ab

Focus on infection prevention technology and strategic partnerships drives growth in high-need therapeutic areas. Q1 2025 saw revenue and EBITDA gains, with ambitious targets set for 2030. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Bactiguard Holding Ab